Kurimoto Ayumu, Ogino Tetsuhiro, Ichii Shinji, Isobe Yoshiaki, Tobe Masanori, Ogita Haruhisa, Takaku Haruo, Sajiki Hironao, Hirota Kosaku, Kawakami Hajime
Research Division, Discovery Research Laboratories II, Sumitomo Pharmaceuticals Co Ltd, Konohana-ku, Osaka 554-0022, Japan.
Bioorg Med Chem. 2003 Dec 1;11(24):5501-8. doi: 10.1016/j.bmc.2003.09.032.
Recently, we have reported the 8-hydroxyadenine derivatives (2-4) as a novel class of interferon (IFN) inducing agents. In the present study, a series of 8-hydroxyadenines, which possess various amino moieties at the adenine C(2)-position, were synthesized and evaluated for their ability to induce endogenous IFN in comparison to the known active agent, Imiquimod. Among the compounds prepared, compound 9o possessing a 2-methoxyethylamino group at C(2)-position of adenine was found to exhibit potent IFN inducing activity in vivo. Compound 9o induced IFN from the dosage of 0.1 mg/kg, which was 30-fold potent than that of Imiquimod, and showed a good oral bioavailability (F=81%).